Cargando…
Combining bioinformatics, network pharmacology and artificial intelligence to predict the mechanism of celastrol in the treatment of type 2 diabetes
BACKGROUND: Type 2 diabetes (T2D) is a common chronic disease with many serious complications. Celastrol can prevent and treat type 2 diabetes by reversing insulin resistance in a number of ways. However, the specific mechanisms by which celastrol prevents and treats T2D are not well understood. The...
Autores principales: | Wu, Ming, Zhang, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627222/ https://www.ncbi.nlm.nih.gov/pubmed/36339449 http://dx.doi.org/10.3389/fendo.2022.1030278 |
Ejemplares similares
-
Integrated bioinformatics, network pharmacology, and artificial intelligence to predict the mechanism of celastrol against muscle atrophy caused by colorectal cancer
por: Wu, Ming, et al.
Publicado: (2022) -
The mechanisms of celastrol in treating papillary thyroid carcinoma based on network pharmacology and experiment verification
por: Yi, Jiaoyu, et al.
Publicado: (2021) -
Investigating Celastrol's Anti-DCM Targets and Mechanisms via Network Pharmacology and Experimental Validation
por: Xi, Rui, et al.
Publicado: (2022) -
Artificial intelligence promotes the diagnosis and screening of diabetic retinopathy
por: Huang, Xuan, et al.
Publicado: (2022) -
Risk factors and drug discovery for cognitive impairment in type 2 diabetes mellitus using artificial intelligence interpretation and graph neural networks
por: Zhang, Xin, et al.
Publicado: (2023)